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Abstract
While total hip arthroplasty remains one of the most reliable procedures with excellent, cost-effective 
outcomes, there remains controversy in the choice of implant in terms of method of fixation, bearing 
surface, and size of the femoral head, especially in the younger population. This review looks at 
the possible information base that surgeons can explore before choosing the implant that they are 
comfortable with. It also looks at the findings of various registries, which readers can use in the 
process of informed consent. We have provided certain recommendations with specific reference to 
the method of fixation, bearing surface, and head size that can be backed by the available registry 
data. However, the information provided should be used only after considering local, financial, and 
patient-specific issues that surgeons encounter on a daily basis during their practice.
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Introduction
Total hip arthroplasty (THA) has 
revolutionized the quality of life of men 
and women of all ages since the 1960s, 
earning the title of “the operation of the 
century.”1 In 2010, a survey of National 
Joint Registries (NJRs) estimated that 
around 959,000 annual primary and 
revision total hip procedures were being 
performed annually with the average 
rate at about 131 procedures per 100,000 
population, and the average revision burden 
was found to be 12.9%. Interestingly, 
57.7% of the patients were women and 
32.9% of patients were under the age of 
65 years.2 On the financial side, the global 
market for a hip replacement has been 
estimated to be around $4.8 billion in 2014 
with an estimated forecast of $5.9 billion 
by 2020.3
The clinical benefit and cost-effectiveness of 
the procedure are well proven. A systematic 
review of the cost-effectiveness has 
estimated the cost of a THA compared with 
no surgery at $10,402 per quality-adjusted 
life year gained. Furthermore, if the 
World Health Organizations’ suggested 
cost-effectiveness threshold of <3 times the 
gross domestic product, or $144,000 based 
on 2011 data for the US, is used, then THA 
can be considered a highly cost-effective 
intervention.4
Long term survival of the prosthesis is 
well investigated in the general population, 
but it is also clear that the survival of 
implants is not as high in the young adults 
[Figure 1].5
While the clinical benefits of a THR are 
well proven, there is a certain amount 
of confusion within the orthopedic 
community in relation to the myriad 
of prosthetic choices available for this 
procedure. Moreover, in an attempt to 
improve the outcome of an already proven 
prosthesis, especially in the younger 
population, surgeons have flirted with 
alternative bearing surfaces and methods 
of fixation.
Despite the vast amount of information 
available on this subject, it is difficult 
to get a unanimous view on the best 
type of prosthesis. The answers to these 
questions remain complex because of the 
large variety of the prosthesis available, 
clouded by variable data from various 
registries, published papers, and agenda 
of the industry. Furthermore, there are 
many factors to consider when choosing 
what prostheses to use for a particular 
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patient including patients’ demographics, the cost of 
the prosthesis, patient reported outcome measures and 
indeed training and comfort of using the implant.
The main aim of this review, therefore, is to discuss the 
controversies in the literature about the best method of 
fixation; the best bearing surface and the optimum size of 
the femoral head.
Materials and Methods
The review discusses in brief the various source of 
information that surgeons can reliably refer to in case of 
total hip arthroplasty surgery. The typical data available 
will be the revision rate and outcome measures from 
various registries and recommendation from bodies 
such as National Institute for Health and Clinical 
Figure 1: A graph showing the Swedish hip arthroplasty register data
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Excellence (NICE) and Orthopaedic Data Evaluation 
Panel (ODEP). Using revision data from registries may 
not be an accurate reflection because the indications for 
revision may vary between surgeons and there remain 
issues with regards to data capture. Moreover, the data 
reported in various registries have some degree of 
inconsistencies.
Following is the summary of our findings of the three 
controversial areas with a brief overview of bodies such as 
NICE, ODEP, and joint registries.
National Institute for Health and Clinical Excellence
NICE publishes guidelines for health professionals to aid 
decision-making and recommend treatments. Currently, 
NICE recommends only those hip prostheses which have 
a revision rate of 5% or less at 10 years.6 This guidance is 
for patients with end-stage arthritis and does not account 
for THRs done for other pathologies such as developmental 
dysplasia of the hip or Perthes disease. NICE also does 
not recommend a certain type of prosthesis, fixation 
method, or bearing surface over another. In their guidance, 
NICE also states that the average cost for a THR varies 
from ≤1557 to ≤3869, depending on the prosthesis and the 
materials used.6 Given the cost implications of THRs on a 
public funded system, it is important to determine specific 
recommendations for the type of prosthesis to be used in a 
specific subset of patients.
Orthopaedic Data Evaluation Panel
ODEP was set up in the UK in 2002 and independently 
evaluates hip prostheses against NICE guidance.7 ODEP 
assigns each implant a benchmark rating so that they can 
be compared with other prostheses on the market that meet 
the NICE guidance. Each implant given an ODEP rating is 
assigned a number (10, 7, 5, or 3) and a letter (A or B). An 
implant assigned a 10 means that there is 10 years worth of 
data that is fully compliant with the NICE benchmarking. 
If an implant is assigned a 7, 5, or 3 it means there is 7, 
5, or 3 years (respectively) of data, and the product is set 
to achieve the 10-year benchmark. The letter indicates the 
strength of the data; A meaning strong evidence and B 
meaning acceptable evidence. The final ratings that ODEP 
can assign are 3A*, 5A*, 7A*, and 10A*. If the implant 
has a revision rate of <3% with a follow-up of at least 
3 years, 3A* is awarded. If an implant has a revision 
rate of <5% at 5, 7, or 10 years, 5A*, 7A*, or 10A* is 
awarded, respectively, if the minimum number of years has 
been reached for each rating.
The use of ODEP rated implants as recorded in the NJR was 
determined in the 10th annual report of the NJR for England, 
Wales and Northern Ireland. For implants with a 10A rating 
on the NJR, a total of 88% of cemented stems, 69% of 
cementless stems, 34% of cemented acetabular components 
and only 3% of cementless acetabular components were 
used8. These figures clearly show that although these 
products have been rated with a globally accepted system 
of benchmarking, autonomy still has a large part to play in 
choosing a prosthesis, along with patient-specific criteria 
and other available data on current implants.
The primary goal of conscientious surgeons would be to 
use a prosthetic combination and perform surgery that will 
meet the NICE benchmark of a 95% survival at 10 years, 
aided by the implants that have achieved the 10A* rating by 
ODEP. However, currently, there are 32 different acetabular 
components and 25 femoral stems that have achieved 10A* 
rating, again giving the surgeons a large variety of implants 
to choose from, but this remains a good database to explore 
before deciding on the final implant.
Joint Registries
Various NJRs have been set up over the last two to three 
decades.
National Joint Registry
The NJR for England, Wales, Northern Ireland, and 
the Isle of Man was established in 2002 and since then 
has collected data on joint replacements to monitor the 
performance and effectiveness of prostheses and surgery, 
respectively. Data from all joint replacements performed in 
the UK is submitted to the NJR, and the rate of compliance 
stands at 96% currently.8 It is the largest available registry 
with more than two million recorded procedures.
The Australian Orthopaedic Association National Joint 
Replacement Registry (AOANJRR)
This registry was set up by the Australian Orthopaedic 
Association in 1999.9 The registry has a large amount of 
data, with 59 different femoral and acetabular combinations 
coupled with 10-year outcome data. However, it is smaller 
than the NJR for England, Wales, Northern Ireland, and 
the Isle of Man, with data for approximately 453,950 hip 
replacements. Of this total, 15.7% are hip hemiarthroplasties, 
72.5% primary THRs, and 11.8% revision THRs.
Unlike the NJR, the Australian Orthopaedic Association 
National Joint Replacement Registry divides THR into 
three different categories: total conventional arthroplasty, 
total resurfacing, and thrust plate. The third is not a method 
commonly used in the UK but includes an acetabular 
component and a femoral head prosthesis with a lateral 
fixation plate. However, conventional THR was the most 
popular choice in the registry, comprising 95% of all the data.
Swedish Hip Arthroplasty Register
This registry was first set up in 1979, making it the 
oldest registry in the International Society of Arthroplasty 
registers.5 The registry also contributes data to the Nordic 
Arthroplasty Register Association10 (NARA). However, the 
Swedish register dates back 28 years before the start of 
NARA. The most recent Swedish hip arthroplasty register 
annual report available is from 2014. Primary THR surgery 
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gained popularity in Sweden between 1992 and 2013, 
increasing by nearly 80%; in 2014 alone 16,565 THRs 
were carried out.
Nordic Arthroplasty Register Association
Another member of the International Society of 
Arthroplasty Registers is the NARA.10 This registry 
combines data from four Nordic countries: Denmark, 
Sweden, Finland and Norway. These four countries 
collaborated to form a common register in 2007 to try and 
improve the quality of joint replacement surgery. Before 
the countries collaborated, each of them had their own 
registry for a number of years; Denmark’s registry was 
founded in 1995, Sweden’s in 1979, Finland’s in 1980, 
and Norway’s in 1987. Due to the discrepancy of when 
each country set up a registry, the NARA includes hip 
arthroplasty data from 1997 up to the present day, but 
the most recent report published is from 2013. There are 
data for 620,261 primary hip replacements in the current 
report, the majority of these operations being performed in 
Sweden.
Results and Discussion
Best method of fixation
The 2015 NJR report8 shows that although uncemented 
implant use has declined since 2010, they are still the most 
used implants (39%) of all THRs [Figure 2]. The use of 
hip resurfacing has declined over the past 6 years with an 
increase in the use of hybrid implants. Hybrid and reverse 
hybrid THRs accounted for 17.1% and 2.4%, respectively, 
of all THRs.
The cemented THR revision rate (3.63% 95% confidence 
interval [CI] 3.43–3.83) was lower than the uncemented 
THR (8.25% 95% CI 7.90–8.62) at 11 years in the 
NJR. However, when this data are looked at closely, 
it seems that the higher revision rate was seen in 
metal-on-metal uncemented THRs as compared with 
ceramic-on-polyethylene uncemented THR, which had a 
revision rate of 3.62% (3.24–4.05). It should also be noted 
that the cemented ceramic-on-polyethylene THR revision 
rate was 2.98% and 2.15% for a hybrid THR.
The Swedish joint registry5 shows a similar trend, and 
although a cemented THR is the most common type of 
fixation, the popularity of it has decreased over recent 
years. Uncemented THR has increased instead. In 2014, 
64.6% of all THRs were cemented, and 20.9% were 
uncemented. Results from 2014 data also show that the 
reverse hybrid THR dropped in popularity comprising 
only 11.2% of all operations, but hybrid THR gained 
popularity to 3% of all THRs. Age clearly has a bearing on 
the type of fixation [Figure 3], with the use of resurfacing 
or uncemented fixation being preferred in the younger 
population.
The Swedish joint registry has previously explored 
the survival of cemented and uncemented femoral and 
acetabular components. Interestingly, they found no 
significant difference between the acetabular component 
survival between the two although there was some 
survival benefit in the younger population with a reduced 
the risk of osteolysis and loosening up to 69 years of 
age [Figure 4], but this was associated with other problems 
that led to revision due to which the total revision risk 
showed no significant difference. The survival of the 
femoral component was significantly better for the 
uncemented components beyond 15 years [Figure 5]. 
However, during the first period after the operation, the 
risk of stem revision is greater if an uncemented stem is 
used; the reason for this difference is primarily revision 
for a periprosthetic fracture [Figure 5]. With the present 
selection of stem types, the risk was 8.8 (CI 6.41–
Figure 2: A graph showing National Joint Registry trend of prosthetic use
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Figure 3: A graph showing the Swedish hip arthroplasty register - prosthetic 
use as per age
Figure 4: The Swedish hip arthroplasty register data comparing cemented and uncemented acetabular components in young patients
12.04, P < 0.0001) times greater for revision due to to a 
periprosthetic fracture within 2 years if an uncemented 
stem instead of a cemented stem was used (Cox regression 
adjusted for age, gender and diagnosis). However, after 
about 8 years, there is a survival advantage of uncemented 
femoral components.
In the AOANJRR9 the trend of using cementless fixation 
has gained popularity, increasing to 63.2% in 2014 from 
51.3% in 2003. This has led to a decline in the use of 
cemented fixation, dropping by 9.5% to 4.4% in 2014 and 
hybrid fixation dropping by 2.4% in the same timeframe. 
In 2014, seven of the ten most popular femoral stems were 
uncemented; 67.3% of all conventional THRs were done 
using these ten most popular stems. Similarly, nine of the 
ten most popular acetabular components were uncemented, 
and 79.4% of all conventional THRs were done with these 
ten components. Furthermore, age and gender have been 
shown to affect revision rate. While men have a slightly 
higher overall revision rate, men and women over 75 years 
old have a lower revision rate as compared with other age 
groups after 6 months. It is also important to note that 
women have a lower revision rate the older they get, for 
men the relationship is not as clear. It was also noted that 
hybrid fixation had a lower revision rate compared with 
cemented or uncemented fixation. Interestingly again, in the 
first 3 months after surgery, uncemented THR had a higher 
revision rate compared with a cemented THR, but after 
3 years, the opposite was true; this may well be related 
to a periprosthetic fracture. Overall, the data suggest that 
uncemented and hybrid fixation were better for the younger 
population (<75 years), but for the over 75, cemented 
combination performed more superiorly.
Recommendation
Most joint registry data favors the use of cemented prosthesis 
in the elderly population, the definition of which can be 
difficult, but physiological patients over the age of 65 years 
will do better with cemented prosthesis with prosthetic 
survival meeting the NICE benchmark of >95% survival 
at 10 years. For the younger population, uncemented and 
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THR as well (37.6%), but ceramic-on-ceramic was also 
a popular choice (34%) [Figure 6]. The NJR data were 
very favorable for ceramic-on-polyethylene articulation 
regardless of whether they are cemented, uncemented or 
hybrids, so it is not surprising to see that these implants 
are becoming more popular. Ceramic on polyethylene 
seems to be the best bearing surface in all groups and when 
combined with hybrid hip replacement had the lowest 
combined revision rate of 2.15% (1.76–2.64).
In the AOANJRR9, the bearing surfaces used comprise 
ceramic, ceramicised metal, metal, cross-linked 
polyethylene, and noncross-linked polyethylene. The 
combination with the lowest revision rate at 14 years was 
Figure 6: National Joint Registry - Temporal change in bearing surface used in primary hip replacement
Figure 5: The Swedish hip arthroplasty register data comparing cemented and uncemented femoral components
hybrids are certainly good options to be considered to 
improve survival, but the results may not meet the NICE 
benchmark in patients younger than 50 years [Figure 1].
Bearing surface
In the NJR8 in 2014, metal on polyethylene remained a 
popular choice for cemented (84.4%), uncemented (41.6%), 
hybrid (58.3%) and reverse hybrid (64.4%) THR, and is 
indeed the most common bearing surface throughout all 
the groups. Only a very small proportion of metal on metal 
bearing surfaces are used now (0.1%). Of all the cemented 
THRs (36.1%), metal-on-polyethylene was the most popular 
bearing surface used (87.8%). This was true for uncemented 
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Figure 7: Use of cross-linked polyethylene– The Swedish hip arthroplasty 
register
Figure 8: The Swedish hip arthroplasty register-Survival advantage of 
Highly crosslinked polyethylene
metal with cross-linked polyethylene (5.4%); although, 
ceramic with cross-linked polyethylene also had low 
revision rates. The combination with the highest revision 
rate at 14 years was metal or ceramic femoral heads with 
noncross-linked polyethylene. Most ceramic on ceramic 
THRs had a cementless method of fixation (85.1%), but 
they actually had a higher rate of revision compared with 
a hybrid method of fixation. Cross-linked polyethylene had 
a lower rate of revision compared with noncross-linked, 
regardless of whether metal, ceramic or ceramicised metal 
femoral head was used. In addition to the overall analysis 
of all the prostheses, the Registry had also undertaken 
analyses on five different acetabular components, each 
of which has been used in large numbers with both 
cross-linked and noncross-linked polyethylene. Three 
of the five prostheses had a lower rate of revision when 
cross-linked polyethylene was used. The other two did not 
show any difference.
In the Swedish registry5 metal with highly cross-linked 
polyethylene [Figure 7] remained the most popular bearing 
surface in the 2014 report (65.9% THRs), but an increase 
in ceramic on highly cross-linked polyethylene (10.9%) 
was also noted.
The use of highly cross-linked polyethylene is expected 
to reduce the risk for acetabular component/liner revisions 
after 5–12 years [Figure 8], the time in which osteolysis 
and/or loosening tends to result in a higher number of 
acetabular component revisions when using the older type 
of polyethylene.
Recommendation
While for the elderly population standard metal on 
polyethylene bearing surface will provide good results 
reaching the standards set by NICE (>95% survival at 
10 years), in the younger population there is benefit 
in using an alternative bearing surface with evidence 
leaning toward the use of ceramic on highly cross linked 
polyethylene, which would improve survival. The registry 
data are certainly more favorable towards this combination 
rather than the ceramic on ceramic articulation.
Head size
The usage of a larger head is gaining traction with 
the recent Swedish joint registry5 report showing that 
the most commonly used femoral head diameter was 
32 mm (71.9%). The use of the 36 mm head had also 
increased by 0.8% to 10.2%.
In the NJR8 for the metal on polyethylene articulation, 
the data are not conclusive but the best survival observed 
was for a head size of <32 mm while for the ceramic 
on polyethylene articulation, the 32 mm head had the 
best survival. The rate of revision using a polyethylene 
monobloc acetabular component has been shown to 
be affected by head size. Using a ceramic or metal 
head of 36 mm with a cemented monobloc acetabular 
component had the highest rate of failure. On the 
uncemented side, a metal-on-polyethylene articulation 
with a head size of 44 mm had the worst outcome. In a 
ceramic-on-polyethylene articulation with an uncemented 
acetabular component, the 28 mm and 36 mm heads had 
the worst rates of failure.
In the AOANJRR9 head size affected rates of revision in a 
ceramic on ceramic THR. A 32 mm head size was found 
to have lower rates of revision when compared with a 
28 mm head size or less, but there was no difference in 
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national databases available, the idea is that the choices can 
become more informed and we have attempted to do the 
same in this review.
All the registries have shown a decline in the use of a 
cemented THR in recent years, even though the cemented 
THR remains the most common implant used. Interestingly, 
Denmark and Sweden reported an equal usage of both 
cemented (50%) and uncemented (50%) THRs.5,10
Although metal on polyethylene bearing surfaces is 
the most popular, there is promising data on ceramics 
as well, and certainly, for the younger adult, a ceramic 
on highly cross-linked polyethylene is the best way 
forward.
As far as the head size is concerned, a 32 mm or less 
comes up at the top for a metal head and a 32 mm for a 
ceramic head.
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